Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis

Efficacy of CAM Interventions in Rheumatoid Arthritis

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00096759

Enrollment

100

Registered

2004-11-16

Start date

2004-11-30

Completion date

2007-08-31

Last updated

2013-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Rheumatoid

Keywords

Arthritis, Tai Chi, Meditation, Relaxation Techniques

Brief summary

The purpose of this study is to compare the effectiveness of relaxation therapy and tai chi in treating the symptoms of rheumatoid arthritis (RA).

Detailed description

RA is a debilitating disease characterized by inflammation of the joints, leading to chronic pain, loss of function, and disability. Complementary and alternative medicine (CAM) treatments are being used with increased frequency by patients with chronic pain and rheumatic diseases to relieve their symptoms. While patients find these treatments helpful, there is limited scientific evidence of the effectiveness of these interventions. This study will compare relaxation therapy (a commonly used treatment for RA) to tai chi chih (a combination of slow, deliberate movements and meditation) in treating the symptoms of RA. Participants will be randomly assigned to receive 12 weeks of either relaxation therapy or tai chi chih. At study entry and Weeks 6 and 12, participants will complete questionnaires about their RA symptoms, health functioning, overall quality of life, and complete a brief medical exam.

Interventions

BEHAVIORALTai Chi Chih

BEHAVIORALRelaxation training

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Active adult onset rheumatoid arthritis * Stable on disease-modifying antirheumatic drugs (DMARDs) or biologic medications * Able to walk without use of an assistive device * Resides in greater Los Angeles area * Willing and able to comply with study requirements

Exclusion criteria

* Uncontrolled or untreated medical conditions * Frequent or uncontrolled disease flares * Use of certain medications any medical condition deemed by the investigators to interfere with either the patient's safe participation or interpretation of the study data

Design outcomes

Primary

Measure	Time frame
RA-related disability	—
Health functioning	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026